Lumos Diagnostics has kicked off a key paediatric study in the US for its FebriDx rapid diagnostic test, marking a ...
Exagen Inc. (Nasdaq: XGN), a leading provider of innovative autoimmune testing, will release financial results for the quarter ended September 30, 2025, before the market opens on Tuesday, November 4, ...
As the Commission prepares a new EU Ports Strategy and a Sustainable Transport Investment Plan, stakeholders say ports should ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback